Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
University of Sydney,Australian Genomic Cancer Medicine Centre
Scientific Title
Single arm, open label, phase II trial of vemurafenib and cobimetinib in patients with metastatic non-squamous non-small cell lung cancer and other tumours harbouring BRAF V600 mutations detected by comprehensive genomic profiling